nsv510521
- Organism: Homo sapiens
- Study:nstd49 (Teague et al. 2010)
- Variant Type:sequence alteration
- Method Type:Optical mapping
- Submitted on:NCBI35 (hg17)
- Variant Calls:4
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:6,001
- Publication(s):Teague et al. 2010
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 660 SVs from 38 studies. See in: genome view
Overlapping variant regions from other studies: 661 SVs from 38 studies. See in: genome view
Overlapping variant regions from other studies: 131 SVs from 6 studies. See in: genome view
Variant Region Placement Information
| Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Outer Start | Outer Stop |
|---|---|---|---|---|---|---|---|---|---|
| nsv510521 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000023.11 | ChrX | 2,787,974 | 2,793,974 |
| nsv510521 | Remapped | Perfect | GRCh37.p13 | Primary Assembly | First Pass | NC_000023.10 | ChrX | 2,706,015 | 2,712,015 |
| nsv510521 | Submitted genomic | NCBI35 (hg17) | Primary Assembly | NC_000023.8 | ChrX | 2,699,376 | 2,705,376 |
Variant Call Information
| Variant Call ID | Type | Sample ID | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | Other Calls in this Sample and Study |
|---|---|---|---|---|---|---|---|---|
| nssv618468 | sequence alteration | CHM | Optical mapping | Optical mapping | Hydatidiform Mole | not provided | Submitter | 1,350 |
| nssv621367 | sequence alteration | GM15510 | Optical mapping | Optical mapping | 1,740 | |||
| nssv622184 | sequence alteration | GM10860 | Optical mapping | Optical mapping | 1,998 | |||
| nssv624086 | sequence alteration | GM18994 | Optical mapping | Optical mapping | 1,936 |
Variant Call Placement Information
| Variant Call ID | Placement Type | Score | Assembly | Reciprocity | Sequence ID | Chr | Outer Start | Outer Stop |
|---|---|---|---|---|---|---|---|---|
| nssv618468 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000023.11 | ChrX | 2,787,974 | 2,793,974 |
| nssv621367 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000023.11 | ChrX | 2,787,974 | 2,793,974 |
| nssv622184 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000023.11 | ChrX | 2,787,974 | 2,793,974 |
| nssv624086 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000023.11 | ChrX | 2,787,974 | 2,793,974 |
| nssv618468 | Remapped | Perfect | GRCh37.p13 | First Pass | NC_000023.10 | ChrX | 2,706,015 | 2,712,015 |
| nssv621367 | Remapped | Perfect | GRCh37.p13 | First Pass | NC_000023.10 | ChrX | 2,706,015 | 2,712,015 |
| nssv622184 | Remapped | Perfect | GRCh37.p13 | First Pass | NC_000023.10 | ChrX | 2,706,015 | 2,712,015 |
| nssv624086 | Remapped | Perfect | GRCh37.p13 | First Pass | NC_000023.10 | ChrX | 2,706,015 | 2,712,015 |
| nssv618468 | Submitted genomic | NCBI35 (hg17) | NC_000023.8 | ChrX | 2,699,376 | 2,705,376 | ||
| nssv621367 | Submitted genomic | NCBI35 (hg17) | NC_000023.8 | ChrX | 2,699,376 | 2,705,376 | ||
| nssv622184 | Submitted genomic | NCBI35 (hg17) | NC_000023.8 | ChrX | 2,699,376 | 2,705,376 | ||
| nssv624086 | Submitted genomic | NCBI35 (hg17) | NC_000023.8 | ChrX | 2,699,376 | 2,705,376 |
No validation data were submitted for this variant
Clinical Assertions
| Variant Call ID | Sample ID | Type | Subject Phenotype | Clinical Interpretation | Source of Interpretation | Gender | Other Calls in this Sample and Study |
|---|---|---|---|---|---|---|---|
| nssv618468 | CHM | sequence alteration | Hydatidiform Mole | not provided | Submitter | Female | 1,350 |